Efficacy and safety of four doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor (PDE4i), in patients with moderate-to-severe COPD
EUROPEAN RESPIRATORY JOURNAL（2019）
关键词
COPD - exacerbations,COPD - management,Airway management
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要